Automated description from the Alliance of Genome Resources (Release 8.3.0)
Predicted to enable dynactin binding activity and phosphatidylinositol-3-phosphate binding activity. Involved in several processes, including cellular response to interleukin-4; multivesicular body-lysosome fusion; and positive regulation of bone resorption. Predicted to be located in endolysosome. Predicted to be active in autophagosome. Is expressed in heart; liver; lung; and metanephros. Orthologous to human RUFY4 (RUN and FYVE domain containing 4).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.